You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS and BRAF wild type

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Circulating Tumour DNA Testing in Assessing for Alterations of

Recruiting
  • Colorectal Cancer
    • Singapore, Singapore
      National University Hospital
    Sep 28, 2021

    Metastatic Colorectal Cancer Trial in China (Anlotinib HCl capsule, Bevacizumab, Oxaliplatin)

    Recruiting
    • Metastatic Colorectal Cancer
    • Anlotinib hydrochloride capsule
    • +3 more
    • Fuzhou, Anhui, China
    • +4 more
    Aug 17, 2021

    Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)

    Active, not recruiting
    • Treatment Related Cancer
    • Munich, Germany
      Ludwig Maximilians University
    Jan 19, 2022

    Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Anaheim, California
    • +47 more
    Mar 28, 2022

    Neoadjuvant Treatment, Rectal Cancer, Cetuximab Trial in Shanghai (cetuximab+mFOLFOX6, short-course radiotherapy)

    Recruiting
    • Neoadjuvant Treatment
    • +3 more
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Apr 15, 2022

    Metastatic Colorectal Cancer Trial (Cetuximab and irinotecan)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Cetuximab and irinotecan
    • (no location specified)
    Jul 26, 2023

    Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

    Recruiting
    • Colorectal Cancer
    • FOLFOX regimen
    • +3 more
    • Madrid, Spain
      Spanish Cooperative Group for the Treatment of Digestive Tumors
    Mar 8, 2022

    Cancer Colorectal Trial in Levallois-Perret (Cetuximab, Irinotecan)

    Recruiting
    • Cancer Colorectal
    • Levallois-Perret, France
      Franco-British Hospital - GCS IHFB Cognacq-Jay
    Aug 25, 2021

    Metastatic Colorectal Cancer Trial in United States (panitumumab, Randomization to No Panitumumab)

    Active, not recruiting
    • Metastatic Colorectal Cancer
    • Basking Ridge, New Jersey
    • +7 more
    Apr 1, 2022

    Cancer of Colon Trial in Jerusalem (Cetuximab)

    Terminated
    • Cancer of Colon
    • Jerusalem, Israel
      Hadassah Ein Kerem
    Aug 2, 2022

    Metastatic Colorectal Cancer Trial in France (Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, Panitumumab, oxaliplatin,

    Recruiting
    • Metastatic Colorectal Cancer
    • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil
    • Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan
    • Avignon, France
    • +5 more
    Aug 2, 2022

    Metastatic Colorectal Cancer. Real-World Data Analysis.

    Completed
    • Metastatic Colorectal Cancer
      • Istanbul, Turkey
        Istanbul Medeniyet University Hospital
      Oct 25, 2021

      Colorectal Tumors Malignant Trial in Shanghai (Tislelizumab Combined With Cetuximab and Irinotecan, Third-line regimens)

      Not yet recruiting
      • Colorectal Neoplasms Malignant
      • Tislelizumab Combined With Cetuximab and Irinotecan
      • Third-line regimens
      • Shanghai, Shanghai, China
        Tianshu Liu
      Apr 18, 2022

      Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

      Recruiting
      • Metastatic Colorectal Cancer
      • Sodium Valproate
      • +2 more
      • Saint Leonards, New South Wales, Australia
      • +8 more
      Jan 22, 2023

      Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

      Completed
      • Metastatic Colon Cancer
      • Trifluridine Tipiracil
      • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
      • Monserrato, CA, Italy
      • +7 more
      Jul 21, 2022

      Colon Cancer Trial in United States (Panitumumab, Nivolumab, Ipilimumab)

      Active, not recruiting
      Has Results
      • Colon Cancer
      • Tampa, Florida
      • +4 more
      Nov 10, 2021

      Metastatic Colorectal Cancer Trial in Beijing (CPGJ602, cetuximab)

      Recruiting
      • Metastatic Colorectal Cancer
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Aug 16, 2021

      Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer Trial (Cetuximab combind mFOLFOX6/FOLFIRI)

      Completed
      • Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
      • Cetuximab combind mFOLFOX6/FOLFIRI
      • (no location specified)
      Jan 17, 2021

      Metastatic Colorectal Cancer Trial in Munich (Irinotecan, Folinic Acid, 5-FU)

      Recruiting
      • Metastatic Colorectal Cancer
      • Munich, Germany
        Klinikum der Universitaet Muenchen - Campus Grosshadern
      Dec 2, 2021

      Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

      Not yet recruiting
      • Colorectal Cancer
      • BRAF V600E Mutation Positive
      • Encorafenib Oral Capsule + Cetuximab
      • (no location specified)
      Jan 30, 2023

      Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)

      Recruiting
      • Metastatic Colorectal Cancer
      • Ann Arbor, Michigan
      • +10 more
      Dec 2, 2022

      RAS Mutation Status in Liquid Biopsies in RAS Wild-type.PERSEIDA

      Completed
      • RAS Wild Type mCRC
        • Almeria, Andalucía, Spain
        • +23 more
        Jun 17, 2021

        Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)

        Active, not recruiting
        • Colorectal Cancer Metastatic
        • Gerona, Barcelona, Spain
        • +17 more
        Jun 29, 2021

        Metastatic Colorectal Adenocarcinoma Trial in Italy (Cetuximab, FOLFIRI, FOLFOX regimen)

        Recruiting
        • Metastatic Colorectal Adenocarcinoma
        • Ancona, AN, Italy
        • +24 more
        Mar 28, 2022